Pacific Sunwear (PSUN) 0.09 $PSUN Four Trending Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pacific Sunwear (PSUN) 0.09 $PSUN

Four Trending Stocks Investors Are Watching On Wednesday 4/6/2016
ACCESSWIRE - Wed Apr 06, 10:25AM CDT
MIAMI, FL / ACCESSWIRE / April 6, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. PSUN, COOL, UNXL, and MSTX have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
UNXL: 1.09 (+0.17), COOL: 0.90 (unch), PSUN: 0.09 (+0.01)

Twitter Rises as MasterCard Hints at a Potential Tie-Up
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 4:08PM CDT
Twitter, Inc. (TWTR) jumped nearly 7% after MasterCard (MA) hinted at a possible collaboration with the micro blogging site as it works on building its own payments system.
PSUN: 0.09 (+0.01), BBY: 31.15 (-0.07), TWTR: 17.26 (+0.21), MA: 94.75 (+0.40)

In Retail, Gap Is More Like an Abyss
at The Street - Tue Apr 05, 9:00AM CDT
The recent rebound is undeserved and the stock should be avoided.
PSUN: 0.09 (+0.01), ANF: 30.64 (-0.15), WMT: 69.04 (+0.40), GPS: 28.86 (+0.17), ARO: 0.27 (+0.02)

Fast Fashion Claims Another Teen Apparel Chain Victim
at The Street - Tue Apr 05, 8:24AM CDT
The once-dominant teen apparel retailer Pacific Sunwear is preparing to file a Chapter 11 bankruptcy filing, according to reports.
PSUN: 0.09 (+0.01), ARO: 0.27 (+0.02)

Retailers Went Zombie Cold During Crucial Holiday Buying Season
at The Street - Mon Apr 04, 6:36PM CDT
Few retailers were hot this winter season but winners include J.C. Penney and Toys 'R' Us.'
BEBE: 0.62 (+0.06), HGG: 1.94 (+0.17), PSUN: 0.09 (+0.01), BONT: 2.09 (-0.04), PLCE: 80.17 (+0.01), TGT: 82.17 (+0.07), JCP: 10.58 (+0.15), SHLD: 14.70 (+0.12), ARO: 0.27 (+0.02)

Buying Stocks: Investors Are Looking At These Equities on April 4th 2016
ACCESSWIRE - Mon Apr 04, 11:15AM CDT
MIAMI, FL / ACCESSWIRE / APRIL 4, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. PSUN, COOL, SKYS, and ARO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
COOL: 0.90 (unch), PSUN: 0.09 (+0.01), SKYS: 4.46 (-1.12), ARO: 0.27 (+0.02)

Penny Stock Trading: Four Stocks Not Joking Around On April Fools
ACCESSWIRE - Fri Apr 01, 1:18PM CDT
MIAMI, FL / ACCESSWIRE / April 1, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. PSUN, GSAT, NVNT, and VLBI have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
PSUN: 0.09 (+0.01)

March 28 Premarket Briefing: 10 Things You Should Know
at The Street - Mon Mar 28, 4:53AM CDT
U.S. stock futures are rising Monday while Asian shares end the session mostly lower.
YHOO: 36.66 (+0.25), AVP: 4.85 (+0.04), PSUN: 0.09 (+0.01), QLIK: 29.62 (+0.54), EMC: 26.41 (+0.02), MSFT: 55.12 (+0.56), SNX: 90.30 (-0.21)

What's in Store for Pacific Sunwear (PSUN) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:00AM CDT
Anaheim, CA-based specialty retailer, Pacific Sunwear of California Inc. (PSUN), is expected to report fourth-quarter fiscal 2015 results on Mar 23.
WBA: 83.69 (+0.33), PSUN: 0.09 (+0.01), GME: 30.09 (-0.20), STZ: 160.34 (+8.98)

Aéropostale to Aggressively Cut Costs, Headcount
at The Street - Thu Jan 14, 7:28AM CST
One industry expert believes the mall-based retailer 'is on life support.'
BEBE: 0.62 (+0.06), HGG: 1.94 (+0.17), PSUN: 0.09 (+0.01), JCP: 10.58 (+0.15), SHLD: 14.70 (+0.12), ARO: 0.27 (+0.02)

5 Retailers That Sought Bankruptcy Protection in 2015
Rich Duprey, The Motley Fool - Motley Fool - Sat Jan 02, 1:24PM CST
Malls may not be the graveyard they were during the recession, but mall-based retailers are still finding it difficult to attract enough customers to survive. Photo: Nicholas Eckhart . It's not unexpected that with the collapse in oil and other...
PSUN: 0.09 (+0.01), S: 3.59 (+0.09), M: 41.57 (+0.10)

The 5 Biggest Retail Flops of 2015
Rich Duprey, The Motley Fool - Motley Fool - Thu Dec 31, 6:36AM CST
In a year that's seen once important mall-based retailers like Aeropostale , bebe , and Pacific Sunwear  lose three-quarters or more of their value and turn into actual penny stocks, choosing the biggest retail flops of 2015 is what I like to call...
BEBE: 0.62 (+0.06), AMZN: 602.08 (+15.94), KSS: 44.86 (-0.05), MW: 13.71 (+0.57), PSUN: 0.09 (+0.01), WMT: 69.04 (+0.40), M: 41.57 (+0.10), ETSY: 8.48 (+0.16), SHLD: 14.70 (+0.12), ARO: 0.27 (+0.02), TJX: 77.59 (-0.12), JCP: 10.58 (+0.15), GPS: 28.86 (+0.17)

Stocks Mixed in Shortened XMas Eve Trading
at The Street - Thu Dec 24, 12:07PM CST
Wall Street ended a shortened week on a mixed note after a touch-and-go morning.
FDX: 162.77 (+0.83), NSC: 81.15 (-0.05), PSUN: 0.09 (+0.01), SUNE: 0.37 (+0.11), CP: 130.05 (-0.70), H: 47.22 (-0.13), CRM: 75.58 (+1.00)

Stocks Try For Gains as Crude Recaptures $38
at The Street - Thu Dec 24, 11:01AM CST
U.S. stocks struggle to secure gains on Thursday after a major rally a day earlier that pushed equities into positive territory for the year.
FDX: 162.77 (+0.83), NSC: 81.15 (-0.05), PSUN: 0.09 (+0.01), SUNE: 0.37 (+0.11), CP: 130.05 (-0.70), H: 47.22 (-0.13), CRM: 75.58 (+1.00)

Stock Futures Higher as Jobless Claims Drop
at The Street - Thu Dec 24, 7:37AM CST
U.S. stock futures edge higher on Thursday in what looks to be a quieter Christmas Eve trading session.
FDX: 162.77 (+0.83), NSC: 81.15 (-0.05), PSUN: 0.09 (+0.01), SUNE: 0.37 (+0.11), CP: 130.05 (-0.70), CRM: 75.58 (+1.00)

Dec. 24 Premarket Briefing: 10 Things You Should Know
at The Street - Thu Dec 24, 5:31AM CST
U.S. stock futures are pointing lower in what's expected to be a quiet trading session ahead of the Christmas holiday.
FDX: 162.77 (+0.83), KBIO: 11.03 (-12.56), PSUN: 0.09 (+0.01), H: 47.22 (-0.13), CRM: 75.58 (+1.00)

What American Eagle Is Doing Right
at The Street - Thu Dec 03, 2:30PM CST
Apparel business is tough, but AEO has its claws in good strategy.
PSUN: 0.09 (+0.01), AEO: 16.09 (+0.04), ARO: 0.27 (+0.02)

Pacific Sunwear Jumps on Narrower-than-Expected Q3 Loss
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 9:10AM CST
Pacific Sunwear of California Inc. (PSUN) reported loss per share of 5 cents in the third-quarter of fiscal 2015 that fared better than the Zacks Consensus Estimate of a loss per share of 7 cents.
PSUN: 0.09 (+0.01), AEO: 16.09 (+0.04), GCO: 69.65 (+0.70), FL: 63.26 (+0.46)

AMERICAN EAGLE OUTFITTERS
at Investor's Business Daily - Wed Dec 02, 5:39PM CST
AMERICAN EAGLE OUTFITTERS (AEO) beat EPS views, while Pacific Sunwear (PSUN) topped and guided above Q4 views. Both gained after hours. AEO said that its holiday retail started strong. Aeropostale (ARO) fell late on mixed results.
PSUN: 0.09 (+0.01), AEO: 16.09 (+0.04), ARO: 0.27 (+0.02)

Pacific Sunwear reports 3Q loss
Automated Insights - Wed Dec 02, 3:56PM CST
ANAHEIM, Calif. (AP) _ Pacific Sunwear of California Inc. (PSUN) on Wednesday reported a loss of $3.4 million in its fiscal third quarter.
PSUN: 0.09 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 83

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

VivoPower Innovates with XRP-Focused Treasury Strategy

Updated Category News Views 359

VivoPower's Transformational XRP Strategy VivoPower International PLC (NASDAQ: VVPR) has recently embarked on a groundbreaking journey by announcing a new strategy centered on the digital asset XRP. The company is positioning itself as the first publicly traded entity to implement an XRP-focused digital asset treasury. This innovative approach is not only exciting for...

Continue Reading
Recognizing Excellence in Product Stewardship for 2024

Updated Category News Views 114

Celebrating Product Stewardship Excellence The Product Stewardship Society has announced a significant honor for 2024—Lynn L. Bergeson has been named the recipient of the prestigious Allan K. Fleeger Distinguished Service Award. This esteemed award has been established to acknowledge the remarkable contributions of individual product stewards who have played crucial...

Continue Reading
Gold Hits New Heights Amid Tensions and Election Uncertainty

Updated Category News Views 163

Gold Prices Surge to Record Heights In recent trading, gold prices have reached unprecedented levels, reflecting a significant rise driven by various factors, including political uncertainties and ongoing international conflicts. As anticipation surrounding a highly competitive U.S. presidential election grows, along with persistent tensions in regions such as the Middle...

Continue Reading
Paul Jebely Joins Sterlington as Aviation Law Vice Chair

Updated Category News Views 257

Paul Jebely Joins Sterlington as New Partner Sterlington PLLC is excited to announce that Paul Jebely has joined the firm as their new Partner and Vice Chair of International, marking a crucial advancement in their aviation law practice. Jebely is not just any attorney; he is a globally recognized authority in private aviation law, especially known for his work with...

Continue Reading
William James Wartinbee III Executes Significant Sell Strategy

Updated Category News Views 62

William James Wartinbee III Implements Key Sell Strategy In a noteworthy insider sale, William James Wartinbee III, the Executive Vice President at Gartner (IT), has sold 210 shares of the company. This transaction was documented in a Form 4 filing with the U.S. Securities and Exchange Commission, and the sale was valued at about $103,275. Examining Gartner's Current...

Continue Reading